Jiangsu Recbio Technology Co., Ltd. (HKG:2179)
Hong Kong · Delayed Price · Currency is HKD 7.57
-0.51 (-6.31%)
Aug 5, 2025, 4:08 PM HKT
Jiangsu Recbio Technology Market Cap
Jiangsu Recbio Technology has a market cap or net worth of 3.70 billion as of August 5, 2025. Its market cap has decreased by -14.10% in one year.
Market Cap
3.70B
Enterprise Value
4.17B
Revenue
28.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.57
Market Cap Chart
Since March 31, 2022, Jiangsu Recbio Technology's market cap has decreased from 12.10B to 3.70B, a decrease of -69.38%. That is a compound annual growth rate of -29.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 3.70B | -18.62% |
| Dec 31, 2024 | 4.55B | -12.74% |
| Dec 29, 2023 | 5.22B | -56.10% |
| Dec 30, 2022 | 11.88B | -1.79% |
| Mar 31, 2022 | 12.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 278.50B |
| Hansoh Pharmaceutical Group Company | 207.51B |
| Innovent Biologics | 158.98B |
| JD Health International | 156.01B |
| Akeso | 140.29B |
| Sino Biopharmaceutical | 130.92B |
| WuXi Biologics | 127.57B |
| CSPC Pharmaceutical Group | 113.07B |